Powder: -20°C for 3 years | In solvent: -80°C for 2 years
Eleutheroside B1 mediates its anti-influenza activity through POLR2A and N-glycosylation. Eleutheroside B1 inhibits the mRNA expression of several chemokine genes and the influenza nucleoprotein (NP) gene, and exhibits low cytotoxicity. Antiviral and anti-inflammatory activities.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 193.00 | |
5 mg | In stock | $ 455.00 | |
10 mg | In stock | $ 657.00 | |
25 mg | In stock | $ 987.00 | |
50 mg | In stock | $ 1,360.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 495.00 |
Description | Eleutheroside B1 mediates its anti-influenza activity through POLR2A and N-glycosylation. Eleutheroside B1 inhibits the mRNA expression of several chemokine genes and the influenza nucleoprotein (NP) gene, and exhibits low cytotoxicity. Antiviral and anti-inflammatory activities. |
In vitro | eleutheroside B1 may affect N?glycan biosynthesis, the chemokine signaling pathway, cytokine?cytokine receptor interaction and, in particular, may target the POLR2A to inhibit the production of influenza virus genes. |
Source |
Molecular Weight | 384.33 |
Formula | C17H20O10 |
CAS No. | 16845-16-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 2 years
DMSO: 75 mg/ml (195.14 mM)
( < 1 mg/ml refers to the product slightly soluble or insoluble )
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Eleutheroside B1 16845-16-2 Microbiology/Virology Influenza Virus Eleutheroside B 1 anti-inflammatory virus host anti-influenza Eleutheroside B-1 Inhibitor genes biosynthesis inhibit inhibitor